Literature DB >> 16145172

Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.

Juliette Pavie1, Claire Lacroix, Dea Garcia Hermoso, Marie Robin, Christèle Ferry, Anne Bergeron, Martine Feuilhade, Françoise Dromer, Eliane Gluckman, Jean-Michel Molina, Patricia Ribaud.   

Abstract

Aspergillus ustus is an uncommon clinical species which is poorly susceptible to antifungals. We report two cases of A. ustus infections that occurred in allogeneic stem cell transplant recipients while they were receiving either voriconazole or caspofungin. Prolonged use of these new antifungal agents may increase the risk of the emergence of resistant organisms.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16145172      PMCID： PMC1234079          DOI： 10.1128/JCM.43.9.4902-4904.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of candida species.

Authors:  Manuel Cuenca-Estrella; Wendy Lee-Yang; Meral A Ciblak; Beth A Arthington-Skaggs; Emilia Mellado; David W Warnock; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

2.  Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.

Authors:  Francisco M Marty; Lisa A Cosimi; Lindsey R Baden
Journal:  N Engl J Med       Date:  2004-02-26       Impact factor: 91.245

3.  Invasive mold infections in allogeneic bone marrow transplant recipients.

Authors:  J W Baddley; T P Stroud; D Salzman; P G Pappas
Journal:  Clin Infect Dis       Date:  2001-04-13       Impact factor: 9.079

4.  Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

Authors:  S Ascioglu; J H Rex; B de Pauw; J E Bennett; J Bille; F Crokaert; D W Denning; J P Donnelly; J E Edwards; Z Erjavec; D Fiere; O Lortholary; J Maertens; J F Meis; T F Patterson; J Ritter; D Selleslag; P M Shah; D A Stevens; T J Walsh
Journal:  Clin Infect Dis       Date:  2001-11-26       Impact factor: 9.079

5.  Primary cutaneous aspergillosis caused by Aspergillus ustus following reduced-intensity stem cell transplantation.

Authors:  K Nakai; Y Kanda; S Mineishi; A Hori; A Chizuka; H Niiya; T Tanimoto; M Ohnishi; M Kami; A Makimoto; R Tanosaki; Y Matsuno; N Yamazaki; K Tobinai; Y Takaue
Journal:  Ann Hematol       Date:  2002-09-24       Impact factor: 3.673

6.  In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates.

Authors:  S Arikan; M Lozano-Chiu; V Paetznick; J H Rex
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

7.  Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

Authors:  Raoul Herbrecht; David W Denning; Thomas F Patterson; John E Bennett; Reginald E Greene; Jörg-W Oestmann; Winfried V Kern; Kieren A Marr; Patricia Ribaud; Olivier Lortholary; Richard Sylvester; Robert H Rubin; John R Wingard; Paul Stark; Christine Durand; Denis Caillot; Eckhard Thiel; Pranatharthi H Chandrasekar; Michael R Hodges; Haran T Schlamm; Peter F Troke; Ben de Pauw
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

8.  Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis.

Authors:  Greg T Siwek; Kirsty J Dodgson; Margarida de Magalhaes-Silverman; Luther A Bartelt; Sara B Kilborn; Peter L Hoth; Daniel J Diekema; Michael A Pfaller
Journal:  Clin Infect Dis       Date:  2004-07-30       Impact factor: 9.079

9.  Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

Authors:  Kieren A Marr; Rachel A Carter; Michael Boeckh; Paul Martin; Lawrence Corey
Journal:  Blood       Date:  2002-08-22       Impact factor: 22.113

Review 10.  Utility of Aspergillus antigen detection in specimens other than serum specimens.

Authors:  Rocus R Klont; Monique A S H Mennink-Kersten; Paul E Verweij
Journal:  Clin Infect Dis       Date:  2004-10-26       Impact factor: 9.079
View more
  19 in total

1.  Diversity and significance of mold species in Norwegian drinking water.

Authors:  Gunhild Hageskal; Ann Kristin Knutsen; Peter Gaustad; G Sybren de Hoog; Ida Skaar
Journal:  Appl Environ Microbiol       Date:  2006-10-06       Impact factor: 4.792

2.  Invasive Aspergillosis of the Hand Caused by Aspergillus ustus: a Case Report.

Authors:  Olushola Olorunnipa; Andrew Y Zhang; Catherine M Curtin
Journal:  Hand (N Y)       Date:  2009-06-30

3.  Cerebral aspergillosis caused by Aspergillus granulosus.

Authors:  Deanna A Sutton; Brian L Wickes; Anna M Romanelli; Michael G Rinaldi; Elizabeth H Thompson; Annette W Fothergill; Megan K Dishop; Okan Elidemir; George B Mallory; Siby P Moonnamakal; Adekunle M Adesina; Marc G Schecter
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

4.  Successful Treatment of Invasive Fungal Infection Due to Highly Resistant Aspergillus calidoustus in an Allogeneic Hematopoietic Cell Transplant Recipient.

Authors:  Maria A Mendoza; Anthony Anderson; Michele I Morris; Lazaros Lekakis; Jacques Simkins; Clara E Prado; Octavio V Martinez; Krishna V Komanduri; Jose F Camargo
Journal:  Mycopathologia       Date:  2020-01-10       Impact factor: 2.574

5.  Update on Antifungal Drug Resistance.

Authors:  David S Perlin; Erika Shor; Yanan Zhao
Journal:  Curr Clin Microbiol Rep       Date:  2015-06-01

6.  In vitro activity of a new oral glucan synthase inhibitor (MK-3118) tested against Aspergillus spp. by CLSI and EUCAST broth microdilution methods.

Authors:  Michael A Pfaller; Shawn A Messer; Mary R Motyl; Ronald N Jones; Mariana Castanheira
Journal:  Antimicrob Agents Chemother       Date:  2012-12-10       Impact factor: 5.191

7.  Aspergillus calidoustus sp. nov., causative agent of human infections previously assigned to Aspergillus ustus.

Authors:  János Varga; Jos Houbraken; Henrich A L Van Der Lee; Paul E Verweij; Robert A Samson
Journal:  Eukaryot Cell       Date:  2008-02-15

8.  Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for Aspergillus spp. for the CLSI M38-A2 broth microdilution method.

Authors:  A Espinel-Ingroff; A Chowdhary; G M Gonzalez; C Lass-Flörl; E Martin-Mazuelos; J Meis; T Peláez; M A Pfaller; J Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

Review 9.  Multi-resistant aspergillosis due to cryptic species.

Authors:  Susan Julie Howard
Journal:  Mycopathologia       Date:  2014-06-27       Impact factor: 2.574

Review 10.  Changing epidemiology of rare mould infections: implications for therapy.

Authors:  Anurag N Malani; Carol A Kauffman
Journal:  Drugs       Date:  2007       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.